MyFinsight
Home
Blog
About
Contact
Download
Download image
Common stock,
preferred stock, and...
$44,128,225
Proceeds from notes and
convertible notes payable,...
$1,191,018
Cash from
subscription receivable
$1,108,751
Proceeds from notes
payable, related party
$678,000
Net cash provided by
financing activities
$30,492,670
Canceled cashflow
$16,613,324
Net increase in cash
$2,365,568
Canceled cashflow
$28,127,102
Redemptions of c-1 preferred
stock
$8,898,442
Repayments of note payable
$6,613,882
Repayments of note payable,
related party
-$793,000
Redemptions of a-1 preferred
stock
$308,000
Impairment of evofem f-1
preferred stock
$23,766,209
Amortization of debt discount
- note payable
$1,706,697
Stock-based compensation
$473,311
Impairment of fixed assets
$412,005
Depreciation expense
$269,271
Accounts receivable
-$43,435
Deposits
-$26,086
Stock-based compensation
from asset purchase
$10,000
Inventory
-$5,471
Amortization of intangible
assets
$3,333
Net increase in cash
$2,365,568
Net cash used in
operating activities
-$25,688,359
Net cash used in
investing activities
-$2,438,743
Canceled cashflow
$26,715,818
Net loss
-$42,787,043
Investment in convertible
notes receivable and...
$2,425,000
Purchase of fixed assets
$13,743
Accounts payable and
accrued expenses
-$5,632,893
Change in fair value of
evofem warrants
-$2,806,983
Prepaid expenses
$613,983
Bargain purchase gain
from purchase of...
-$328,071
Amortization of debt discount
- note receivable
$220,689
Change in fair value of
derivative liability
-$14,515
Back
Back
Cash Flow
source: myfinsight.com
ADTX
ADTX